Jianying Lei

3PUBLICATIONS
4CO-AUTHORS
Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteins
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Oct 01, 2025
Cost-effectiveness of sequential treatment strategies involving first-line pembrolizumab with trastuzumab and chemotherapy for unresectable metastatic HER2-positive gastric or gastroesophageal junction adenocarcinoma.

Caicong You, Jiahao Zhang, Jianying Lei

|Aug 04, 2025
Cost-effectiveness of perioperative durvalumab plus neoadjuvant chemotherapy for muscle invasive bladder cancer in the United States.

Caicong You, Jiahao Zhang, Jianying Lei

|Nov 25, 2024
First-line treatment with zolbetuximab plus CAPOX for ClDN18.2-positive gastric or gastroesophageal junction adenocarcinoma: a cost-effectiveness analysis.

Jianying Lei, Jiahao Zhang, Caicong You

Pageof 1

Frequent Collaborators

2 joint publications

Jiahao Zhang

2 joint publications

Maobai Liu

2 joint publications

Hongfu Cai

1 joint publications

Caicong You